These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13971725)

  • 1. Ocular manifestations of familial hypercholesterolemia.
    BLODI FC; YARBROUGH JC
    Am J Ophthalmol; 1963 Apr; 55():714-8. PubMed ID: 13971725
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular manifestations of familial hypercholesterolemia.
    BLODI FC; YARBROUGH JC
    Trans Am Ophthalmol Soc; 1962; 60():304-15. PubMed ID: 13971724
    [No Abstract]   [Full Text] [Related]  

  • 3. [IDIOPATHIC HYPERCHOLESTEREMIA IN A 4-YEAR-OLD CHILD].
    TZONOS P; SPANOS C; AEDONOPOULOS G; KONSTANTINOU K
    Hell Iatr; 1963 Jun; 32():619-26. PubMed ID: 14075367
    [No Abstract]   [Full Text] [Related]  

  • 4. [ESSENTIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    BEAUMONT JL; BEAUMONT V; CLAUDE JR
    Acta Cardiol; 1965; 20():45-59. PubMed ID: 14303245
    [No Abstract]   [Full Text] [Related]  

  • 5. Essential familial hypercholesterolemia.
    WILKINSON CF; HAND EA; FLIEGELMAN MT
    Ann Intern Med; 1948 Oct; 29(4):671-86. PubMed ID: 18890269
    [No Abstract]   [Full Text] [Related]  

  • 6. [Essential familial xanthomatous hypercholesteremia and a therapy trial with triparanol].
    MEISINGER FX
    Arztl Forsch; 1963 Jan; 17():39-44. PubMed ID: 13934599
    [No Abstract]   [Full Text] [Related]  

  • 7. [CHEMICAL COMPOSITION OF SF O-12 LIPOPROTEINS IN FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    BEAUMONT JL; SWYNGHEDAUW B; BEAUMONT V
    Rev Fr Etud Clin Biol; 1965 Feb; 10():221-4. PubMed ID: 14309899
    [No Abstract]   [Full Text] [Related]  

  • 8. [JUVENILE CORONARY DISEASE DURING FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    KHOURI RM
    Rev Atheroscler; 1964; 6():83-6. PubMed ID: 14223340
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a relationship in pathogenesis between arteriosclerosis and familial hypercholesteremia?
    THANNHAUSER SJ
    Bull New Engl Med Cent; 1950 Aug; 12(4):129-33. PubMed ID: 15434572
    [No Abstract]   [Full Text] [Related]  

  • 10. ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA AND XANTHOMATOUS HEART DISEASE.
    SANCHEZ-VALENTIN R; GARCIA-PALMIERI MR
    Bol Asoc Med P R; 1963 Sep; 55():359-71. PubMed ID: 14051425
    [No Abstract]   [Full Text] [Related]  

  • 11. THE OCULAR MANIFESTATIONS OF EXPERIMENTAL HYPERCHOLESTERAEMIA IN RABBITS.
    FRANCOIS J; NEETENS A
    Ophthalmologica; 1964; 148():57-79. PubMed ID: 14185134
    [No Abstract]   [Full Text] [Related]  

  • 12. ASTEROID HYALITIS: RELATIONSHIP TO DIABETES AND HYPERCHOLESTEROLEMIA.
    BARD LA
    Am J Ophthalmol; 1964 Aug; 58():239-42. PubMed ID: 14202509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Familial essential hypercholesteremia and xanthomatosis; katamnestic and continued studies of 12 Danish families].
    PIPER J; ORRILD L
    Ugeskr Laeger; 1955 Oct; 117(43):1397-405. PubMed ID: 13281958
    [No Abstract]   [Full Text] [Related]  

  • 14. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; HENRY C
    Coeur Med Interne; 1963 Oct; 58():405-11. PubMed ID: 14092610
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON XANTHOMATOSIS CAUSED BY ESSENTIAL HYPERCHOLESTEROLEMIA].
    PISANI M; BIONDI C; DELUCA M
    Minerva Dermatol; 1964 Jun; 39():159-66. PubMed ID: 14178499
    [No Abstract]   [Full Text] [Related]  

  • 16. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEROLEMIA. BIOCLINICAL AND THERAPEUTIC STUDY].
    LEURIDAN B
    J Sci Med Lille; 1965 Feb; 83():137-8. PubMed ID: 14308373
    [No Abstract]   [Full Text] [Related]  

  • 17. Current practices in general medicine. 11. Essential hypercholesteremia and its management.
    JUERGENS JL; ACHOR RW
    Proc Staff Meet Mayo Clin; 1959 Nov; 34():533-42. PubMed ID: 14408093
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular changes in experimental hypercholesteremia.
    COGAN DG; KUWABARA T
    AMA Arch Ophthalmol; 1959 Feb; 61(2):219-25. PubMed ID: 13616784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.